EXAGEN INC. - COMMON STOCK

Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors

28 апр 2025 09:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

21 апр 2025 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

11 мар 2025 08:00:01 Источник Nasdaq GlobeNewswire

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025

25 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in Upcoming Investor Conferences

04 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

12 янв 2025 12:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

12 дек 2024 09:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

14 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

13 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2024 Results

12 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

29 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

21 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

04 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance

05 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

02 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire

Exagen Appoints Jeffrey G. Black as New Chief Financial Officer

01 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2024 Results on August 5, 2024

22 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

13 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Exagen Announces Campaign for Lupus Awareness Month

06 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2024 Results on May 13, 2024

30 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire